Deep Track Capital, LP Pyxis Oncology, Inc. Transaction History
Deep Track Capital, LP
- $2.71 Billion
- Q3 2024
A detailed history of Deep Track Capital, LP transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, Deep Track Capital, LP holds 4,184,100 shares of PYXS stock, worth $8.37 Million. This represents 0.57% of its overall portfolio holdings.
Number of Shares
4,184,100
Previous 4,184,100
-0.0%
Holding current value
$8.37 Million
Previous $13.8 Million
10.87%
% of portfolio
0.57%
Previous 0.45%
Shares
1 transactions
Others Institutions Holding PYXS
# of Institutions
101Shares Held
28.2MCall Options Held
539KPut Options Held
54.1K-
Laurion Capital Management LP New York, NY3.63MShares$7.25 Million0.18% of portfolio
-
Black Rock Inc. New York, NY2.79MShares$5.57 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.43MShares$4.87 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.91MShares$3.81 Million0.0% of portfolio
-
Blue Owl Capital Holdings LP New York, NY1.13MShares$2.25 Million1.36% of portfolio
About Pyxis Oncology, Inc.
- Ticker PYXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,096,400
- Market Cap $70.2M
- Description
- Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...